1. The collection of new therapeutic entities first launched in 2011 originated from the following sources: Prous Integrity Database; Thomson-Reuters Pipeline Database; The Pink Sheet; Drugs@FDA Website; FDA News Releases; IMS R&D Focus; Adis Business Intelligence R&D Insight; Pharmaprojects.
2. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnovation/ucm285554.htm.
3. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280525.htm.
4. http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm267592.htm.
5. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202331lbl.pdf.